Insulin resistance and oral cancer risk

Horizons in Cancer Research. Volume 43

Volumn , Issue , 2011, Pages 77-97

  Suba, Zsuzsanna ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Elevated fasting glucose; Insulin resistance; Metabolic syndrome; Obesity; Oral cancer risk; Type 2 diabetes

Indexed keywords

EID: 84867495423     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (146)

1. Adami HO, Chow WH, Nyren O: Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88:1472-1476, 1996
2. Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ: The Associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women: meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomark & Prev 11:1441-1448, 2002
3. Altmore E, Vendemiale G, Chicco D et al: Increased lipid peroxidation in type 2 poorly controlled diabetic patient. Diabetes Metab 18:264-271, 1992
4. Auluck A: Diabetes mellitus: an emerging risk factor for oral cancer J Can Dent Assoc 73:501-503, 2007
5. Augustin LSA, Gallus S, Franceschi S, Negri E, Jenkins D, Kendall CWC, dal Maso L, Talamini R, La Vecchia C: Glycemic index and load and risk of upper aero-digestive tract neoplasms. Cancer Causes & Control 14:657-662, 2003
6. Augustin L, Gallus S, Negri E, La Vecchia C: Glycemic index, glycemic load and risk of gastric cancer. Ann Oncol, 15:581-584, 2004
7. Augustin LS, Galeone C, Dal Maso L, Pelucchi C, Ramazotti V, Jenkins DJ, Montella M, Talamini R, Negri E, Franceschi S, La Vecchia C: Glycemic index, glycemic load and risk of prostate cancer. Int J of Cancer 112:446-450, 2004
8. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G: Alcohol consumption and the risk of cancer: a meta-analysis. Alcohol Res & Health 25:263-270, 2001
9. Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM: Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 109:54-59, 2007
10. Balkau B, Kahn H, Courbon D, Eschwege E, Ducimetiere P: Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: The Paris Prospective Study. Diabetes Care 24: 843-849, 2001
11. Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1-9, 1999
12. Beulens JW, Stolk RP, van der Schouw YT, Grobbee DE, Hendriks HF, Bots ML: Alcohol consumption and risk of type 2 diabetes among older women. Diabetes Care 28:2933-2938, 2005
13. Bhawal UK, Ozaki Y, Nishimura M: Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma. Oncology 69:246-255, 2005
14. Binnie WH, Rankin KV, Mackenzie IC: Etiology of oral squamous cell carcinoma. J Oral Path 12:11-29, 1983
15. Bloomgarden ZT: Definitions of the insulin resistance syndrome: The 1st World Congress on the Insulin Resistance Syndrome. Diabetes Care 27:824, 2004
16. Bosetti C, Negri E, Franceschi S, Pelucchi C, Talamini R, Montella M, Conti E, La Vecchia C: Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer, 93:911-915, 2001
17. Bosetti C, Gallus S, Trichopoulou A, Talamini R, Franceschi S, Negri E, La Vecchia C: Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract. Cancer Epidemiol Biomark & Prev 12:1091-1094, 2003
18. Brown LM: Epidemiology of alcohol-associated cancers. Alcohol 35:161-168, 2005
19. Brownlee M: Glycation and diabetic complications. Diabetes 43:836-841, 1994.
20. Calle EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer, 4:579-591, 2004
21. Carboni JM, Lee AV, Hadsell DL, Rowley BR, Lee FY, Bol DK, Camuso AE, Gottardis M, Greer AF, Ho CP, Hurlburt W, Li AX, Saulnier M, Velaparthi U, Wang C, Wen ML, Westhouse RA, Wittman M, Zimmermann K, Rupnow BA, Wong TW: Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res 65:3781-2005
22. Charron MJ, Lodish HF: Molecular physiology of glucose transporters. Diabetes Care 13:209-218, 1990
23. Chlebowsky RT, Aiello E, McTiernan A: Weight loss in breast cancer management. J Clin Oncol 20:1128-1143, 2002
24. Chlebowsky RT: Obesity and early-stage breast cancer. J Clin Oncol, 23:1345-1347, 2005
25. Clandinin MT, Cheema CJ, Field ML, Garg J, Vendatraman J, Clandinin TR: Dietary fat: exogenous determination of membrane structure and cell function. FASEB J 5:2761, 1991
26. Clayman L: Oral cancer. A practical guide to understanding oral cancer. ELLM Press, 2002
27. Cowey S, Hardy RW: The metabolic syndrome: A high-risk state for cancer Am J Pathol 169:1505-1522, 2006
28. Dang CV, Semenza GL: Oncogenic alterations of metabolism. Trends Biochem Sci 24:68-72, 1999
29. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
30. Del Giudice ME, Fantus IG, Ezzat S, Mckeown-Eyssen G, Page D, Goodwin PJ: Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47:111-120, 1998
31. Ding XZ, Feshenfeld DM, Murphy L et al: Physiological concentrations of insulin augment pancreatic cell proliferation and glucose utilization by activating MAP kinase, P13 kinase and enhancing GLUT-1 expression. Pancreas 21:310-320, 2000
32. Döbrossy L. Cancer mortality in central-eastern Europe: Facts behind the figures. Lancet Oncol 3:374-381, 2002
33. Duncan G, Perri M, Theriaque D et al: Exercise training, without weight loss increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care 26:557-562, 2003
34. Egan BM: Insulin resistance and sympathetic nervous system. Curr Hypertens Rep 5:247-254, 2003.
35. Eliasson B, Attval S, Taskinen MR, Smith U: The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler & Thromb 14:1946-1950, 1994
36. Facchini FS, Hollenbeck CB, Jeopesen J: Insulin resistance and cigarette smoking. Lancet 339:1128-1130, 1992
37. Facchini FS, Hua N, Abbasi F, Raven GM: Insulin resistance as a predictor of age related diseases. J Clin Endocrinol & Metab 86:3574-3578, 2001
38. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA: Effects of fatty acids on glucose production and utilization in man. J. Clin. Invest. 72:1737, 1983
39. Field CJ, Ryan EA, Thomson ABR, Clandinin MT: Diet fat composition alters membrane phospholipid composition, insulin binding and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem 265:43, 1990
40. Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among U. S. adults. Diabetes Care 27: 2444-2449, 2004
41. Franceschi S, Talamini R, Barra S, Baron Ae, Negri E, Bidoli E, Serraino D, Lavecchia C: Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and esophagus in Northern Italy. Cancer Res 50:6502-6507, 1990
42. Franceschi S, Favero A, Conti E, Talamini R, Volpe R, Negri E, Barzan L, La Vecchia C: Food groups, oils and butter, and cancer of the oral cavity and pharynx. Cancer 80:614-620, 1999
43. Franceschi S, Dal Maso L, Levi F, Conti E, Talamini R, La Vecchia C: Leanness as early marker of cancer of the oral cavity and pharynx. Ann Oncol, 12:331-336, 2001
44. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Ellison RC: Alcohol consumption and the prevalence of the metabolic syndrome in the U. S. A cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care 27:2954-2959, 2004
45. Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Buring JE, Freudenheim JL, Goldbohm RA, Harnack L, Hankinson SE, Larsson SC, Leitzmann M, McCullough ML, Marshall J, Miller AB, Rodriguez C, Rohan TE, Schatzakin A, Schouten LJ, Wolk A, Zhang SM. Smith-Warner SA: Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer 94:757-762, 2006
46. Gerlain-Biquez C, Vol S, Tichet J, Caradec A, D'Hour A, Balkau B: The metabolic syndrome in smokers: the D.E.S.I.R. study. Diabetes Metab 29:226-234, 2003
47. Giovannucci E. Pollak M. Liu Y. Platz EA. Majeed N. Rimm EB. Willett WC: Nutritional predictors of insulin-like growth factor I and their relationships in men. Cancer Epidemiol Biomark & Prev 12:84-89, 2003
48. Golf DC, Zaccaro DJ, Haffner SM et al: Insulin sensitivity and risk the risk of incident hypertension: insights from the insulin resistance. (Atherosclerosis Study). Diabetes Care 26:805-809, 2003
49. Gould GW, Holman GD: The glucose transporter family: structure, function and tissuespecific expression. Biochem J 295:329-341, 1993
50. Gupta K, Krishnaswamy G, Karnad A, Peiris AN: Insulin: A novel factor in carcinogenesis. Am J Med Sci 323:140-145, 2002
51. Higginbotham S, Zhang ZF, Lee IM, Cook NR, Giovanucci E, Buring JE, Liu S: Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. J Natl Cancer Inst, 96:229-233, 2004
52. Hirose K, Toyama T, Iwata H et al. Insulin, insulin-like growth factor-1 and breast cancer risk in Japanese women. Asian Pac J Cancer Prev 4:239-246, 2003
53. Hu G: Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly diagnosed diabetes. Diabetologia. 46:608-617, 2000
54. Hussain SP, Hofseth LJ, Harris CC: Radical causes of cancer. Nat Rev Cancer 3:276-285, 2003
55. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M: Association between smoking, hematological parameters, and metabolic syndrome in Japanese men. American Diabetes Association 29:741, 2006
56. Iype EM, Pandey M, Mathew A, Thomas G, Sebastian P, Nair MK: Oral cancer among patients under the age of 35 years. J Postgrad Med 47:171-176, 2001
57. Jee SH, Ohrr H, Sull JW, YunJE, Ji M, Samet JM: Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194-202, 2005
58. Johnson NW, Warnakulasuriya KAAS: Epidemiology and aetiology of oral cancer in the United Kingdom. Commun Dental Health 10:13-29, 1993
59. Johnson NW: Etiology and risk factors for oral cancer, with special reference to tobacco and alcohol use. Hungarian Oncol (English abstr) 45:115-122, 2001
60. Jump DB, Clarke SD, Thelen A, Liimatta M, Ren B, Badin MV: Dietary fat, genes and human health. Adv Experiment Med Biol 422:167-176, 1997
61. Kademani D: Oral cancer. Mayo Clin Proc 82:878-887, 2007
62. Kahn CR, Folli F: Molecular determinant of insulin action. Hormon Res. 39:93-101, 1993
63. Kahn CR: Insulin receptors and insulin signaling in normal and disease states. In:Alberti KGM, Zimmet P, DeFronzo RA, Keen H, (eds): International Textbook of Diabetes mellitus. 2nd ed. pp. 437-466. John Wiley and Sons, Chichester, 1997
64. Key TJ, Applyby PN, Reeves GK: Body mass index, serum sex hormones and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95: 1218-1226, 2003
65. Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC: Diet, nutrition and the prevention of cancer. Public Health Nutr 1:187-200, 2004
66. Kido Y, Nakae J, Accili D: Clinical review: The insulin receptor and its cellular targets. J Clin Endocrinol Metab 86: 972-979, 2001
67. Kim YI: Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link Nutr Rev 56:275-279, 1998
68. Kirstein M, Aston C, Hintz R, Vlassara H: Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest, 90:439-446, 1992
69. Koistinen HA, Zierath JR: Regulation of glucose transport in human skeletal muscle. Ann Med 34:410-418, 2003
70. Kriska A, Pereira M, Hanson R et al: Association of physical activity and serum insulin concentration in two populations at high risk to type 2 diabetes, but differing by BMI. Diabetes Care 24:1175-1180, 2001
71. Krolls SO, Hoffman S: Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14,253 cases by age, sex, and race of patients. JADA 92:571-574, 1976
72. Kunkel M, Reichert TE, Benz P: Overexpression of Glut-1 and increased metabolism in tumors are associated with poor prognosis in patients with oral squamous cell carcinoma. Cancer 97:1015-1024, 2003
73. Kuriki K, Hirose K, Tajima K: Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev 16:83-89, 2007
74. Landsberg L. Insulin mediated sympathetic stimulation: role in the pathogenesis of obesity related hypertension (or how insulin affects blood pressure and why). Hypertension 19:523-528, 2001
75. La Vecchia C, Chatenoud L, Altieri A, Tavani A: Nutrition and health: epidemiology of diet, cancer and cardiovascular disease in Italy. Nutr Met & Cariovasc Dis 11:10-15, 2001
76. La Vecchia C: Mediterranean diet and cancer. (Review). Public Health Nutr 7:965-968, 2004
77. La Vecchia C, Lucchini F, Negri E, Levi F: Trends in oral cancer mortality in Europe. Oral Oncol 40:433-439, 2004
78. Lehmann R, Vokac A, Niedermann K, Agosti K, Spinas GA: Loss of abdominal fat improvement of cardiovascular risk profile by regular moderate exercise training in patients with NIDDM. Diabetologia 38:1313-1319, 1995
79. Levi F, Lucchini F, Negri E, Zatonski W, Boyle P, La Vecchia C: Trends in cancer mortality in the European Union and accession countries, 1980-2000. Ann Oncol 15:1425-1431, 2004
80. Leroith D, Baserga R, Helman L, Roberts CT: Insulin-like growth factors and cancer. Ann Intern Med 122:54-59, 1995
81. Lindblad P, Chow WH, Chan J: The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologica 42:107-112, 1999
82. Llewellyn CD, Johnson NW, Warnakulasuriya KAAS: Risk factors for squamous cell carcinoma of the oral cavity in young people-a comprehensive literature review. Oral Oncol 37:401-418, 2001
83. Llewellyn CD, Johnson NW, Warnakulasuriya KA: Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med 33:525-532, 2004
84. Macfarlane GJ, Boyle P: Rising mortality from cancer of the tongue in young Scottish males. The Lancet 2:912,Abstract 1987
85. Malasanos TH, Stacpoole PW: Biological effects of ω-3 fatty acids in diabetes mellitus. Diabetes Care 14:1160, 1991
86. Mangelsdorf D, Thummel C, Beatoo M et al: The nuclear receptor superfamily: the second decade. Cell 83:835-839, 1995
87. Manicardi V, Camellini L, Bellodi G. et al: Evidence for an association of high blood pressure and hyperinsulinemia in obese men. J Clin Endocrinol Metab 62:1302-1304, 1986
88. McKeown-Eyssen G: Epidemiology of colorectal cancer revisited: are serum triglycerides and plasma glucose associated with risk Cancer Epidemiol Biomark & Prev 3:687-695, 1994
89. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G: Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139:802-809, 2003
90. McTiernan A: Associations between energy balance and body mass index and risk of breast carcinoma in a women from diverse racial and ethnic backgrounds in the U.S. cancer. Cancer 88:1248-1255, 2000
91. Mealey BL, Moritz AJ: Hormonal influences: effects of diabetes mellitus and endogenous female sex steroid hormones on the periodontium. Periodontology 2000. 32:59-81, 2003
92. Meyer M, Schreck R, Muller JM, Baeuerle PA: Redox control of gene expression by eukaryotic transcription factors NF-6B, AP-1, and SRF/TCF. In: Pasquier C, Olivier RY, Auclair C, Packer L. (Eds.), Oxidative Stress, Cell Activation and Viral Infection. Birkhauser Verlag, Basel, pp. 217-235, 1994
93. Michels KB, Ekbom A: Caloric restriction and incidence of breast cancer. JAMA 291-1226-1230, 2004
94. Morse DE, Psoter WJ, Cleveland D, Cohen D, Mohit-Tabatabai M, Kosis DL, Eisenberg E: Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes & Control 1800:919-929, 2007
95. Muti P, Quattrin T, Grant BJB, Krogh V, Micheli A, Schunemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F: Fasting glucose is a risk factor for breast cancer. Cancer Epidemiol Biomark & Prev 11:1361-1368, 2002
96. Nestler JE: Obesity, insulin, sex steroids and ovulation. Int J Obesity & Related Metab Disorders 24: 571-573, 2000
97. Neville BW, Day TA: Tumors and precancerous lesions of the oral cavity. CA Cancer J Clin 52:195-215, 2002
98. Nilsen TI, Vatten LJ: Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer 84:417-422, 2001
99. Nishino Y, Wakai K, Kondo T, Seki N, Ito Y, Suzuki K, Ozasa K, Watanabe Y, Ando M, Tsubono Y, Tsuji I, Tamakoshi A; JACC Study Group. Alcohol consumption and lung cancer mortality in Japan collaborative cohort ( JACC ) study. J Epidemiol 16:49-56, 2006
100. Nunez NP, Oh WJ, Rozenberg J, Perella C, Anver M, Barrett JC, Perkins SN, Berrigan D, Moitra J, Varticovski L, Hursting SD, Vinson C: Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. Cancer Res 66:5469-5476, 2006
101. Ogihara S, Yamada M, Saito T et al: Insulin potentiated mitogenic effect of epidermal growth factor on cultured guinea pig gastric mucous cells. Am J Physiol 271:104-112, 1996
102. Olefsky JM: The insulin receptor: a multifunctional protein. Diabetes 39:1009-1016, 1990
103. Oliver RJ, Woodwards RT, Sloan P: Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Transplantational Research Fund studies. Eur J Cancer 40:503-508,2004
104. Padmanabham TK, Sankaranarayanan M, Nair MK: Evaluation of local control, survival and pattern of failure with radiotherapy in cancer of the tongue. Oncology 47:121-123, 1990
105. Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y: Association of obesity and cancer risk in Canada. Am J Epidemiol 159:259-268, 2004
106. Poschl G, Seitz HK: Alcohol and Cancer. Alcohol & Alcoholism. 39:155-165, 2004
107. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK: Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49: 945-952, 2006
108. Reaven GM: Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
109. Reaven GM: Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev 44:121-131, 1993
110. Reaven GM: Insulin resistance, cardiovascular disease, and the metabolic syndrome: How well do the emperor's clothes fit Diabetes Care 27:1011-1012, 2004
111. Reiser KM: Nonenzymatic glycation of collagen in aging and diabetes. Proc. Soc. Exp Biol Med 218:23-37, 1998
112. Rich AM, Radden BG: Squamous cell carcinoma of the oral mucosa: a review of 244 cases in Australia. J Oral Pathol 13:459-471, 1984
113. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ: Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and hemostatic factors. BMJ 319:1523-1528, 1999
114. Rogers MA, Yamamoto C, King DS et al: Improvement in glucose tolerance after 1 week of exercise in patients with mild NIDDM. Diabetes Care 11:613-618, 1988
115. Sasahira T, Kirita T, Bhawal UK, Yamamoto K, Ohmori H, Fujii K, Kuniyasu H:Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma. Histopatology 51:166-172, 2007
116. Schantz SP, Yu GP: Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 128:268-274, 2002
117. Schmidt AM, Hori O, Cao R: RAGE a novel cellular receptor for advanced glycation end products. Diabetes 45:77-80, 1996
118. Schmidt AM, Weidman E, Lalla E, Yan SD, Hori O, Cao R, Brett JG, Lamster IB:Advanced glycation end products (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res 31:508-515, 1996
119. Schneider JG, Tompkins C, Blumenthal RS, Mora S: The metabolic syndrome in women. Cardiol Rev 14:286-291, 2006
120. Shao L, Huang Q, Luo M, Lai M: Detection of the differentially expressed gene IGFbinding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients. Endocr Relat Cancer 11:141-148, 2004
121. Sierksma A, Patel H, Ouchi N, Kihara S, Funahashi T, Heine R, Grobbee DE, Kluft C, Hendriks HFJ: Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor alpha and insulin sensitivity. Diabetes Care 24:184-189, 2004
122. Singh B, Bhaya M, Zimbler M, Stern J, Roland JT, Rosenfeld RM, HarEl G, Lucente FE: Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 20:1-7, 1998
123. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, La Vecchia C: Hypertension and hormone-related neoplasms in women. Hypertension 34:320-325, 1999
124. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G, Kaaks R:Prospective study of hyperglycemia and cancer risk. Diabetes Care 30:561-567, 2007
125. Steinberg HO, Charker H, Leaming R et al: Obesity/insulin resistance is associated with endothel dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610, 1996
126. Suba Zs, Barabás J, Szabó Gy, Takács D, Ujpál M: Increased prevalence of diabetes and obesity in patients with salivary gland tumors. Diabetes Care 28:228, 2005
127. Suba Zs, Barabás J, Takács D, Szabó Gy, Ujpál M: Epidemiological correlations of insulin resistance and salivary gland tumors (in Hungarian). Orvosi Hetilap 146:1727-1732, 2005.
128. Suba Zs, Ujpál M: Correlations of insulin resistance and tumor risk (in Hungarian). Magyar Onkológia 50:127-135, 2006
129. Suba Zs, Barabás J: Prevention of oral cancer (in Hungarian) pp. 17-20. Medicina ZRT, Budapest, 2007
130. Suba Zs, Ujpál M: Disorders of glucose metabolism and oral cancer risk. Fogorv Szle 100:250-257, 2007
131. Suba Zs: Gender-related hormonal risk factors for oral cancer. Pathol. Oncol. Res. 13:195-202, 2007
132. Suba Zs: Systemic risk factors for oral cancer: Estrogen deficiency and insulin resistance. Chapter 8. pp. 157-172 In: Progress in Oral Cancer Research. Ed: Frederik L. Nielsen. Nova Science Publishers. 2008
133. Tatar M, Bartke A, Antebi A: The endocrine regulation of aging by insulin like signals. Science 299:1346-1351, 2003
134. Tavani A, Giordano L, Gallus S, Talamini R, Franceschi S, Giacosa A, Montella M, La Vecchia C: Consumption of sweet foods and breast cancer risk in Italy. Annals of Oncology 17:341-345, 2006
135. Taylor B, Rehm J, Gmel G: Moderate alcohol consumption and the gastrointestinal tract. Dig Dis 23:170-176, 2005
136. Ujpál M, Matos O. Bíbok Gy, Somogyi A, Szabó Gy, Suba Zs: Diabetes and oral tumors in Hungary: Epidemiological correlations. Diabetes Care 27:770-774, 2004
137. Voskuil DW, Vrieling A, van't Veer LJ, Kampman E, Rookus MA: The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies. Cancer Epidemiol Biomark & Prev 14:195-203, 2005
138. Vlassara H: Recent progress in advanced glycation end products and diabetic complications. Diabetes 46:19-25, 1997
139. Warburg O: On the origin of cancer cells. Science (Wash DC), 123:309-314, 1956
140. Welsch CW: Dietary fat, calories and experimental mammary gland tumorigenesis. Cancer Res 52:S2040, 1992
141. Werner H, Katz J: The emerging role of insulin-like growth factors in oral biology (Review). J Dental Res 83:832-836, 2004
142. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
143. Wu ShI, Chou P, Tsai ShT: The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol 54:117-120, 2001
144. Wynder EL, Bross IJ, Feldman RM: A study of the etiological factors in cancer of the mouth. Cancer 10:1300-1323, 1957
145. Yeung NG, Husain I, Waterfall N: Diabetes mellitus and bladder cancer. An epidemiological relationship Pathol Oncol Res 9: 30-31, 2003
146. Yu H, Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92:1472-89, 2000